APA (7th ed.) Citation

Y, T., K, S., K, K., Y, Y., R, H., A, K., . . . Y, O. (2025). Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma. BMC cancer, 25(1), 1873. https://doi.org/10.1186/s12885-025-15267-6

Chicago Style (17th ed.) Citation

Y, Toyohara, et al. "Synthetic Lethality from the Combination of a Histone Methyltransferase SUV39H2 Inhibitor and a Poly (ADP-ribose) Polymerase Inhibitor for Uterine Leiomyosarcoma." BMC Cancer 25, no. 1 (2025): 1873. https://doi.org/10.1186/s12885-025-15267-6.

MLA (9th ed.) Citation

Y, Toyohara, et al. "Synthetic Lethality from the Combination of a Histone Methyltransferase SUV39H2 Inhibitor and a Poly (ADP-ribose) Polymerase Inhibitor for Uterine Leiomyosarcoma." BMC Cancer, vol. 25, no. 1, 2025, p. 1873, https://doi.org/10.1186/s12885-025-15267-6.